lymphoma

Researchers found that the addition of brentuximab vedotin to standard chemotherapy improves overall survival in people with Hodgkin Lymphoma.

Hematologist Dr. Carrie Thompson discusses what people can expect after treatment for lymphoma and how to achieve the best quality of life.

Learn about CAR-T cell therapy, a personalized treatment giving hope to patients diagnosed with various lymphomas.

The American Society of Hematology (ASH) recognized Mayo Clinic hematologist Stephen Ansell, M.D., with the highly distinguished Ernest Beutler Lecture and Prize in recognition of his significant contributions to the field of lymphoma research.

A study led by Mayo Clinic researchers Zhi Zhang Yang, M.D., and Stephen M. Ansell, M.D., Ph.D., has found that healthy white blood cells called[...]

Stephen M. Ansell, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, discusses his lymphoma research.